15-52319254-A-G
Variant names: 
Variant summary
Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1
The NM_001382347.1(MYO5A):c.5040T>C(p.Asp1680Asp) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.175 in 1,613,882 control chromosomes in the GnomAD database, including 32,274 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
 Genomes: 𝑓 0.20   (  3977   hom.,  cov: 32) 
 Exomes 𝑓:  0.17   (  28297   hom.  ) 
Consequence
 MYO5A
NM_001382347.1 synonymous
NM_001382347.1 synonymous
Scores
 2
Clinical Significance
Conservation
 PhyloP100:  -2.49  
Publications
22 publications found 
Genes affected
 MYO5A  (HGNC:7602):  (myosin VA) This gene is one of three myosin V heavy-chain genes, belonging to the myosin gene superfamily. Myosin V is a class of actin-based motor proteins involved in cytoplasmic vesicle transport and anchorage, spindle-pole alignment and mRNA translocation. The protein encoded by this gene is abundant in melanocytes and nerve cells. Mutations in this gene cause Griscelli syndrome type-1 (GS1) and neuroectodermal melanolysosomal disease, or Elejalde disease. [provided by RefSeq, Sep 2023] 
MYO5A Gene-Disease associations (from GenCC):
- Griscelli syndrome type 1Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: ClinGen, G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics
- Griscelli syndrome type 3Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.86). 
BP6
Variant 15-52319254-A-G is Benign according to our data. Variant chr15-52319254-A-G is described in ClinVar as Benign. ClinVar VariationId is 255655.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. 
BP7
Synonymous conserved (PhyloP=-2.49 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.555  is higher than 0.05. 
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt | 
|---|---|---|---|---|---|---|---|---|
| MYO5A | NM_001382347.1 | c.5040T>C | p.Asp1680Asp | synonymous_variant | Exon 39 of 42 | ENST00000399233.7 | NP_001369276.1 | 
Ensembl
Frequencies
GnomAD3 genomes  0.204  AC: 30963AN: 151924Hom.:  3977  Cov.: 32 show subpopulations 
GnomAD3 genomes 
 AF: 
AC: 
30963
AN: 
151924
Hom.: 
Cov.: 
32
Gnomad AFR 
 AF: 
Gnomad AMI 
 AF: 
Gnomad AMR 
 AF: 
Gnomad ASJ 
 AF: 
Gnomad EAS 
 AF: 
Gnomad SAS 
 AF: 
Gnomad FIN 
 AF: 
Gnomad MID 
 AF: 
Gnomad NFE 
 AF: 
Gnomad OTH 
 AF: 
GnomAD2 exomes  AF:  0.227  AC: 56554AN: 249560 AF XY:  0.226   show subpopulations 
GnomAD2 exomes 
 AF: 
AC: 
56554
AN: 
249560
 AF XY: 
Gnomad AFR exome 
 AF: 
Gnomad AMR exome 
 AF: 
Gnomad ASJ exome 
 AF: 
Gnomad EAS exome 
 AF: 
Gnomad FIN exome 
 AF: 
Gnomad NFE exome 
 AF: 
Gnomad OTH exome 
 AF: 
GnomAD4 exome  AF:  0.172  AC: 251218AN: 1461840Hom.:  28297  Cov.: 34 AF XY:  0.177  AC XY: 128617AN XY: 727228 show subpopulations 
GnomAD4 exome 
 AF: 
AC: 
251218
AN: 
1461840
Hom.: 
Cov.: 
34
 AF XY: 
AC XY: 
128617
AN XY: 
727228
show subpopulations 
African (AFR) 
 AF: 
AC: 
9220
AN: 
33480
American (AMR) 
 AF: 
AC: 
12335
AN: 
44724
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
6511
AN: 
26136
East Asian (EAS) 
 AF: 
AC: 
22905
AN: 
39700
South Asian (SAS) 
 AF: 
AC: 
30307
AN: 
86258
European-Finnish (FIN) 
 AF: 
AC: 
4064
AN: 
53416
Middle Eastern (MID) 
 AF: 
AC: 
1092
AN: 
5768
European-Non Finnish (NFE) 
 AF: 
AC: 
152936
AN: 
1111964
Other (OTH) 
 AF: 
AC: 
11848
AN: 
60394
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.489 
Heterozygous variant carriers
 0 
 12480 
 24959 
 37439 
 49918 
 62398 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
 0 
 5968 
 11936 
 17904 
 23872 
 29840 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
GnomAD4 genome  0.204  AC: 30982AN: 152042Hom.:  3977  Cov.: 32 AF XY:  0.206  AC XY: 15310AN XY: 74338 show subpopulations 
GnomAD4 genome 
 AF: 
AC: 
30982
AN: 
152042
Hom.: 
Cov.: 
32
 AF XY: 
AC XY: 
15310
AN XY: 
74338
show subpopulations 
African (AFR) 
 AF: 
AC: 
11190
AN: 
41426
American (AMR) 
 AF: 
AC: 
3437
AN: 
15278
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
871
AN: 
3468
East Asian (EAS) 
 AF: 
AC: 
2952
AN: 
5160
South Asian (SAS) 
 AF: 
AC: 
1775
AN: 
4820
European-Finnish (FIN) 
 AF: 
AC: 
692
AN: 
10600
Middle Eastern (MID) 
 AF: 
AC: 
53
AN: 
294
European-Non Finnish (NFE) 
 AF: 
AC: 
9562
AN: 
67976
Other (OTH) 
 AF: 
AC: 
377
AN: 
2110
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.502 
Heterozygous variant carriers
 0 
 1180 
 2360 
 3540 
 4720 
 5900 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
 0 
 336 
 672 
 1008 
 1344 
 1680 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
Alfa 
 AF: 
Hom.: 
Bravo 
 AF: 
Asia WGS 
 AF: 
AC: 
1726
AN: 
3478
EpiCase 
 AF: 
EpiControl 
 AF: 
ClinVar
Significance: Benign 
Submissions summary: Benign:4 
Revision: criteria provided, multiple submitters, no conflicts
LINK: link 
Submissions by phenotype
not provided    Benign:3 
Jan 30, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Aug 06, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not specified    Benign:1 
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 BayesDel_noAF 
 Benign 
 DANN 
 Benign 
 PhyloP100 
Splicing
Name
Calibrated prediction
Score
Prediction
 SpliceAI score (max) 
Details are displayed if max score is > 0.2
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.